|
|
Article: R&D specialist aquired to bolster Thomson Pharma.(Centre for Medicines Research International acquired by Thomson Corp. Thomson Scientific, research and development)(Brief article)
- Article from:
- Information World Review
- Article date:
- May 8, 2006
- Author:
CopyrightCOPYRIGHT 2006 Incisive Media, published with the permission of Incisive Media. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: Mark Chillingworth
R&D specialist acquired to bolster Thomson Pharma
Mark Chillingworth
Thomson Scientific has acquired a highly specialised pharmaceutical information provider to add R&D benchmarking information and consulting to Thomson Pharma.
Epsom-based Centre for Medicines Research International (CMR) has been acquired for an undisclosed sum.
"Lately there has been an interest by pharmaceutical companies to compare the R&D performance of the industry with their own and that of their close rivals," said Peter Joshua, CMR VP, of the information it adds to the Pharma portfolio. CMR collects information directly ...